E W Lamon

1.5k total citations
69 papers, 1.2k citations indexed

About

E W Lamon is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Genetics. According to data from OpenAlex, E W Lamon has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 24 papers in Radiology, Nuclear Medicine and Imaging and 18 papers in Genetics. Recurrent topics in E W Lamon's work include Monoclonal and Polyclonal Antibodies Research (23 papers), Immunotherapy and Immune Responses (20 papers) and T-cell and B-cell Immunology (17 papers). E W Lamon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (23 papers), Immunotherapy and Immune Responses (20 papers) and T-cell and B-cell Immunology (17 papers). E W Lamon collaborates with scholars based in United States, Sweden and Italy. E W Lamon's co-authors include H Skurzak, Birger Andersson, Hans Wigzell, E. Klein, Eva Klein, Dirck L. Dillehay, E W Fuson, J. Bennett, Ellen W. Collisson and Michael W. Shaw and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

E W Lamon

68 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E W Lamon United States 20 800 398 340 213 201 69 1.2k
Dieter Armerding United States 16 991 1.2× 197 0.5× 204 0.6× 149 0.7× 76 0.4× 34 1.3k
John J. Farrar United States 13 1.1k 1.4× 235 0.6× 371 1.1× 194 0.9× 79 0.4× 25 1.5k
D E Kern United States 15 1.5k 1.9× 342 0.9× 351 1.0× 556 2.6× 135 0.7× 21 1.9k
T Diamantstein Germany 19 747 0.9× 151 0.4× 242 0.7× 227 1.1× 97 0.5× 57 1.2k
W. R. Fleischmann United States 18 689 0.9× 117 0.3× 202 0.6× 329 1.5× 79 0.4× 54 1.1k
Yi‐chi M. Kong United States 19 655 0.8× 187 0.5× 134 0.4× 70 0.3× 284 1.4× 45 1.1k
V. Wallis United Kingdom 16 850 1.1× 207 0.5× 233 0.7× 115 0.5× 96 0.5× 32 1.3k
C. Kurahara United States 9 648 0.8× 98 0.2× 353 1.0× 154 0.7× 88 0.4× 12 1.1k
Diane Y. Mochizuki United States 9 999 1.2× 147 0.4× 379 1.1× 312 1.5× 144 0.7× 10 1.5k
David A. Rhodes United Kingdom 18 961 1.2× 142 0.4× 526 1.5× 174 0.8× 103 0.5× 24 1.6k

Countries citing papers authored by E W Lamon

Since Specialization
Citations

This map shows the geographic impact of E W Lamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E W Lamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E W Lamon more than expected).

Fields of papers citing papers by E W Lamon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E W Lamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E W Lamon. The network helps show where E W Lamon may publish in the future.

Co-authorship network of co-authors of E W Lamon

This figure shows the co-authorship network connecting the top 25 collaborators of E W Lamon. A scholar is included among the top collaborators of E W Lamon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E W Lamon. E W Lamon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Powell, Thomas, et al.. (1995). Moloney leukemia virus-induced cell surface antigen mimicry by monoclonal antibodies. Immunologic Research. 14(4). 292–316. 1 indexed citations
2.
Marshall, Gary S., et al.. (1993). Detection of Two Early Gene Products of Epstein–Barr Virus by Fluorescence Flow Cytometry. Viral Immunology. 6(2). 97–107. 7 indexed citations
3.
Jiang, Xiao Ling, Michael P. Everson, & E W Lamon. (1993). A mechanism of retinoid potentiation of murine T-cell responses: Early upregulation of interleukin-2 receptors. International Journal of Immunopharmacology. 15(3). 309–317. 14 indexed citations
4.
Lamon, E W, et al.. (1992). Differential effects of human recombinant interferons on the expression of two early gene products of Epstein-Barr virus. Antiviral Research. 17(1). 79–89. 5 indexed citations
5.
Ryan, Thomas M., et al.. (1990). Thymus-dependent antiidiotype and anti-antiidiotype responses to a dinitrophenyl-specific monoclonal antibody.. The Journal of Immunology. 145(1). 202–208. 9 indexed citations
6.
Dillehay, Dirck L., et al.. (1989). Effects of retinoids on human thymus-dependent and thymus-independent mitogenesis. Clinical Immunology and Immunopathology. 50(1). 100–108. 13 indexed citations
7.
Pruitt, Kenneth M., et al.. (1989). In Vitro Effect of Acetaldehyde on Cell‐Mediated Cytotoxicity by Murine Spleen Cells. Alcoholism Clinical and Experimental Research. 13(6). 766–771. 5 indexed citations
8.
Powell, Thomas, et al.. (1988). Activation of a functional idiotype network response by monoclonal antibody specific for a virus (M-MuLV)-induced tumor antigen.. The Journal of Immunology. 140(9). 3266–3272. 12 indexed citations
9.
Lindamood, Charles, Dirck L. Dillehay, E W Lamon, et al.. (1988). Toxicologic and immunologic evaluations of N-(all-trans-retinoyl)-dl-leucine and N-(all-trans-retinoyl)glycine. Toxicology and Applied Pharmacology. 96(2). 279–295. 11 indexed citations
10.
Lamon, E W, et al.. (1982). Complementation between Infecting Epstein-Barr Virus and Intrinsic Viral Genomes in Human Lymphoid Cell Lines. Intervirology. 18(1-2). 66–75. 4 indexed citations
11.
Shaw, Michael W., E W Lamon, & Richard W. Compans. (1982). Immunologic studies on the influenza A virus nonstructural protein NS1.. The Journal of Experimental Medicine. 156(1). 243–254. 7 indexed citations
12.
Lamon, E W, et al.. (1982). Antiviral effects of interferon on a somatic cell hybrid between two Burkitt's lymphoma cell lines of different interferon sensitivities. Infection and Immunity. 36(2). 847–849. 1 indexed citations
13.
Fuson, E W, et al.. (1979). Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: No requirement for exogenous C5. Clinical Immunology and Immunopathology. 14(1). 35–46. 8 indexed citations
14.
15.
16.
Lamon, E W, et al.. (1975). IgM-induced tumor cell cytotoxicity mediated by normal thymocytes.. The Journal of Experimental Medicine. 142(2). 542–547. 22 indexed citations
17.
Lamon, E W & Hans Wigzell. (1974). IN VITRO ACTIVITY OF SUBPOPULATIONS OF IMMUNE LYMPHOCYTES AGAINST MURINE SARCOMA CELL,S. Transplantation. 18(4). 368–370. 3 indexed citations
18.
Lamon, E W, Hans Wigzell, E. Klein, Birger Andersson, & H Skurzak. (1973). THE LYMPHOCYTE RESPONSE TO PRIMARY MOLONEY SARCOMA VIRUS TUMORS IN BALB/c MICE. The Journal of Experimental Medicine. 137(6). 1472–1493. 101 indexed citations
19.
Skurzak, H, Eva Klein, Takato O. Yoshida, & E W Lamon. (1972). SYNERGISTIC OR ANTAGONISTIC EFFECT OF DIFFERENT ANTIBODY CONCENTRATIONS ON IN VITRO LYMPHOCYTE CYTOTOXICITY IN THE MOLONEY SARCOMA VIRUS SYSTEM. The Journal of Experimental Medicine. 135(4). 997–1002. 64 indexed citations
20.
Lamon, E W, H Skurzak, E. Klein, & Hans Wigzell. (1972). IN VITRO CYTOTOXICITY BY A NONTHYMUS-PROCESSED LYMPHOCYTE POPULATION WITH SPECIFICITY FOR A VIRALLY DETERMINED TUMOR CELL SURFACE ANTIGEN. The Journal of Experimental Medicine. 136(5). 1072–1079. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026